专家访谈

关注糖尿病合并冠心病患者——Sheryl F. Kelsey教授访谈

International Diabetes: BARI 2D study shows that intensive medical therapy based on prompt revascularization therapy has no advantage in reducing the ....

糖尿病合并心血管疾病患者的希望:BARI 2D研究——沈卫峰教授访谈

《国际糖尿病》:请您谈谈对BARI 2D研究的认识? 沈卫峰教授:这个研究在PubMed上公布时,我正巧受邀去日本的一个学术会议上作糖尿病冠心病治疗策略的讲座,因此我仔细阅读了这篇文献。BARI2D研究已经做了5年,其总体结论是对于糖尿病合并有冠心病的患者药物治疗效果很好,跟PCI的总体疗效基本相....

罗格列酮在糖尿病治疗中的地位不容忽视——Hanefeld M教授专访

International Diabetes:  The main purpose of the RECORD study is to evaluate the cardiovascular safety of rosiglitazone. How do you feel about th....

RECORD研究的启示——Henning Beck-Nielsen教授访谈

International Diabetes: The RECORD study proved rosiglitazone does not increase the risk of overall cardiovascular morbidity or mortality compred with....

[ADA2009]Dan Ziegler教授专访——抗氧化应激引领糖尿病治疗新理念

International Diabetes: At this ADA conference, your presentation is that Oxidative Stress Predicts the Progression of Peripheral and Cardiac A....

[ADA2009]ADA大会主席R.Paul Robertson教授专访

International Diabetes: It has been shown that chronic oxidative stress is an important mechanism whereby glucose excess can damage beta-cells in ty....

[ADA2009]Steven Willi教授专访:影响糖代谢的激素

International Diabetes: Good afternoon Dr. Willi. The prevalence of glucocorticoid-induced hyperglycaemia in common diabetic and non-diabetic indivi....

[ADA2009] Pittas教授谈维生素D与糖尿病发生风险

Anastassios G. Pittas  美国塔夫茨大学医学中心 <International Diabetes>: Good afternoon Dr. Peters. In addition to its effect on bone metabolism, Vita....

[ADA2009]John D. Brunzell教授访谈:综合干预危险因素,全面降低心血管风险

采访实录: International Diabetes: Cardiovascular disease is one of the major complications in diabetes mellitus, it is important to assess and manage....

[ADA2009]哈佛大学医学院David Nathan教授访谈:衡量血糖控制新尺度

  采访实录: International Diabetes:  A linear relationship between HbA1C and average blood glucose levels has been observed the ADAG study whi....
 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

国际糖尿病(www.idiabetes.com.cn)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。

国际糖尿病 版权所有  2008-2018 idiabetes.com.cn  All Rights Reserved